Cas:3418-45-9 1,2,3,4-Tetrahydro-3-quinolinol manufacturer & supplier

Chemical Name:1,2,3,4-Tetrahydro-3-quinolinol

CAS.NO:3418-45-9

Synonyms:1,2,3,4-Tetrahydro-chinazolin;1,2,3,4-Tetrahydro-chinolin-3-ol;1,2,3,4-tetrahydroquinolin-3-ol;1,2,3,4-tetrahydro-quinolin-3-ol;1,2,3,4-Tetrahydro-carbazol-9-carbonsaeure-amid;1,2,3,4-Tetrahydro-3-quinolinol;1,2,3,4-Tetrahydro-9H-carbazole-9-carboxamide;tetrahydroquinazoline;1,2,3,4-tetrahydro-quinazoline;1,2,3,4-Tetrahydrocarbazol-N-carboxamid;3-Quinolinol, 1,2,3,4-tetrahydro-;1,2,3,4-Tetrahydrochinolin-3-ol;1,2,3,4-tetrahydro-carbazole-9-carboxylic acid amide

Molecular Formula:C₉H₁₁NO

Molecular Weight:149.190

HS Code:2933499090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:318.7±31.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.586

PSA:32.26000

Exact Mass:149.084061

LogP:0.74

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,2,3,4-Tetrahydro-chinazolin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2,3,4-tetrahydro-carbazole-9-carboxylic acid amide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3,4-Tetrahydrochinolin-3-ol Use and application,1,2,3,4-Tetrahydro-chinazolin technical grade,usp/ep/jp grade.

Related News: Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. 1,2,3,4-Tetrahydro-3-quinolinol manufacturer Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies. 1,2,3,4-Tetrahydro-3-quinolinol supplier China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. 1,2,3,4-Tetrahydro-3-quinolinol vendor Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high. 1,2,3,4-Tetrahydro-3-quinolinol factory Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.